Mining multi-item drug adverse effect associations in spontaneous reporting systems

BMC Bioinformatics

Volumn 11, Issue SUPPL. 9, 2010, Pages

  Harpaz, Rave ^a   Chase, Herbert S ^a   Friedman, Carol ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EFFECT; ASSOCIATION ANALYSIS; DATA MINING METHODS; DRUG ADVERSE EFFECTS; PHARMACOVIGILANCE; QUALITY OF DATA; REPORTING SYSTEMS; REPRESENTATIVE SAMPLE;

DATA MINING;

DRUG PRODUCTS;

DRUG;

ALGORITHM; ARTICLE; DATA MINING; DRUG POTENTIATION; DRUG SURVEILLANCE PROGRAM; FACTUAL DATABASE; FOOD AND DRUG ADMINISTRATION; METHODOLOGY; STATISTICS; UNITED STATES;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ALGORITHMS; DATA MINING; DATABASES, FACTUAL; DRUG SYNERGISM; PHARMACEUTICAL PREPARATIONS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 78049477630     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-11-S9-S7     Document Type: Article

References (27)

1. Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, Small SD, Sweitzer BJ, Leape LL. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA 1997, 277:307-311. 10.1001/jama.277.4.307, 9002493.
2. Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA 1997, 277:301-306. 10.1001/jama.277.4.301, 9002492.
3. Adverse Event Reporting System. , http://www.fda.gov/cder/aers/default.htm
4. The Upsala monitoring centre. , http://www.who-umc.org
5. Welcome to MedDRA and the MSSO. , http://www.meddramsso.com/MSSOWeb/index.htm
6. Hauben M, Madigan D, Gerrits CM, Walsh L, van Puijenbroek EP. The role of data mining in pharmacovigilance. Expert Opin Drug Saf 2005, 4:929-948. 10.1517/14740338.4.5.929, 16111454.
7. Wilson AM, Thabane L, Holbrook A. Application of data mining techniques in pharmacovigilance. Br J Clin Pharmacol 2004, 57:127-134. 10.1046/j.1365-2125.2003.01968.x, 1884444, 14748811.
8. Almenoff J, Tonning JM, Gould AL, Szarfman A, Hauben M, Ouellet-Hellstrom R, Ball R, Hornbuckle K, Walsh L, Yee C, et al. Perspectives on the use of data mining in pharmaco-vigilance. Drug Saf 2005, 28:981-1007. 10.2165/00002018-200528110-00002, 16231953.
9. Bate A, Evans SJ. Quantitative signal detection using spontaneous ADR reporting. Pharmacoepidemiol Drug Saf 2009, 18:427-436. 10.1002/pds.1742, 19358225.
10. Szarfman A, Machado SG, O'Neill RT. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and events in the US FDA's spontaneous reports database. Drug Saf 2002, 25:381-392. 10.2165/00002018-200225060-00001, 12071774.
11. Bate A, Lindquist M, Edwards IR, Olsson S, Orre R, Lansner A, De Freitas RM. A Bayesian neural network method for adverse drug reaction signal generation. Eur J Clin Pharmacol 1998, 54:315-321. 10.1007/s002280050466, 9696956.
12. Stephenson W, Hauben M. Data mining for signals in spontaneous reporting databases: proceed with caution. Pharmacoepidemiol Drug Saf 2007, 16:359-365. 10.1002/pds.1323, 17019675.
13. van Puijenbroek EP, Egberts AC, Meyboom RH, Leufkens HG. Signalling possible drug-drug interactions in a spontaneous reporting system: delay of withdrawal bleeding during concomitant use of oral contraceptives and itraconazole. Br J Clin Pharmacol 1999, 47:689-693. 10.1046/j.1365-2125.1999.00957.x, 2014250, 10383548.
14. Bharat T, Grundschober S, Doessegger L. Detecting signals of drug-drug interactions in a spontaneous reports database. Br J Clin Pharmacol 2007, 64:489-495. 10.1111/j.1365-2125.2007.02900.x, 2048563, 17506784.
15. Brossette SE, Sprague AP, Hardin JM, Waites KB, Jones WT, Moser SA. Association rules and data mining in hospital infection control and public health surveillance. J Am Med Inform Assoc 1998, 5:373-381. 61314, 9670134.
16. Ma L, Tsui F, Hogan W, Wagner M, Ma H. A framework for infection control surveillance using association rules. 410-414.
17. Chen J, He H, Li J. Representing association classification rules mined from health data. 1225-1231. Berlin/Heidelberg.
18. Rouane H, Toussaint Y, Valtchev P. Mining signals in spontaneous reports database using concept analysis. Berlin/Heidelberg.
19. Agrawal R, Imielinski T, Swami A. Mining association rules between sets of items in large databases. SIGMOD 1993, 207-216.
20. Friedman C, Shagina L, Lussier Y, Hripcsak G. Automated encoding of clinical documents based on natural language processing. J Am Med Inform Assoc 2004, 11:392-402. 10.1197/jamia.M1552, 516246, 15187068.
21. Unified Medical Language System. , http://www.nlm.nih.gov/research/umls/rxnorm/
22. DuMouchel W. Bayesian data mining in large frequency tables, with an application to the FDA Spontaneous Reporting System. Am Stat 1999, 53:177-190.
23. Madigan D. Data Mining in Large Frequency Tables, with an Application to the FDA Spontaneous Reporting System: Discussion. Am Stat 1999, 53:198-200.
24. Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf 2001, 10:483-486. 10.1002/pds.677, 11828828.
25. Micromedex® Healthcare Series [Internet database]. Greenwood Village, Colo: Thomson Reuters (Healthcare) Inc. Updated periodically. 2010,
26. Hauben M, Reich L, DeMicco J, Kim K. `Extreme Duplication' in the US FDA Adverse Events Reporting System Database. Drug Safety 2007, 30(6):551-554. 10.2165/00002018-200730060-00009, 17536881.
27. Noren GN, Sundberg R, Bate A, Edwards IR. A statistical methodology for drug-drug interaction surveillance. Stat Med 2008, 27:3057-3070. 10.1002/sim.3247, 18344185.